Paper
Development of a Technology for Efficiently Discovering Diverse Antibody Candidates Using Artificial Intelligence
Multi-Objective Amortized CDRH3 Sequence Sampling Diversifies Promising Antibody Candidates
- What
- Researchers have developed a new artificial intelligence-based antibody sequence generation technology that can simultaneously consider multiple conditions and diversity during the antibody design process.
- Key result
- Compared to existing methods, it generated 10 times more diverse and acceptable antibody candidates at a 50 percent sequence identity.
- Why it matters
- This research can help reduce the probability of failure in the early stages of new drug development and explore various potential antibody candidates.AI summary